Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a Web-based dashboard for providers; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; appointments solution for online appointments, reminders, and referral tracking; and patient activation solution that enables providers to communicate with their patients through surveys, announcements, messaging, and health campaigns. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and PRO data for approximately 25 specialties; and life sciences solution to deliver targeted and clinically relevant marketing content to patients, as well as COVID-19 product offerings for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was founded in 2005 and is headquartered in Raleigh, North Carolina.
IPO Year: 2019
Exchange: NYSE
Website: phreesia.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/27/2025 | $36.00 | Outperform | Mizuho |
| 1/8/2025 | $24.00 → $32.00 | Sector Perform → Outperform | RBC Capital Mkts |
| 2/26/2024 | $35.00 | Buy | Truist |
| 1/17/2024 | $30.00 → $32.00 | Neutral → Buy | DA Davidson |
| 1/3/2024 | $29.00 | Overweight | Barclays |
| 4/12/2023 | $37.00 | Overweight | Stephens |
| 1/4/2023 | $35.00 → $40.00 | Buy | Needham |
| 12/13/2022 | $40.00 | Neutral → Buy | Citigroup |
| 12/9/2022 | $31.00 → $34.00 | Mkt Perform → Outperform | SVB Leerink |
| 10/13/2022 | $25.00 | Neutral | DA Davidson |
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - Phreesia, Inc. (0001412408) (Issuer)
4 - Phreesia, Inc. (0001412408) (Issuer)
4 - Phreesia, Inc. (0001412408) (Issuer)
4 - Phreesia, Inc. (0001412408) (Issuer)
4 - Phreesia, Inc. (0001412408) (Issuer)
4 - Phreesia, Inc. (0001412408) (Issuer)
4 - Phreesia, Inc. (0001412408) (Issuer)
4 - Phreesia, Inc. (0001412408) (Issuer)
4 - Phreesia, Inc. (0001412408) (Issuer)
Fastest customizable press release news feed in the world
New offering enhances Phreesia's existing platform, eliminating long hold times and ensuring every patient call is resolved Phreesia, a leader in patient activation, today announced the launch of Phreesia VoiceAI, an always-on, intelligent AI phone solution purpose-built for healthcare. VoiceAI leverages advanced natural language processing and real-time workflow integration to help healthcare organizations manage high call volumes, streamline routine interactions and improve the patient experience—all without increasing staff workload. VoiceAI allows patients to easily resolve common requests by using patients' natural spoken language. VoiceAI then triages and routes those patient requ
Phreesia, a leader in patient intake, outreach and activation that enables one in seven patient visits across the U.S., and Sesame Workshop, the global nonprofit behind Sesame Street, are pleased to announce a collaboration to educate and engage parents and caregivers of young children at the point of care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250821354173/en/Phreesia and Sesame Workshop announce new collaboration With the help of Sesame Street's beloved characters like Elmo, Cookie Monster and Abby Cadabby, the two organizations will engage millions of parents and caregivers with educational and entertaining messages
Phreesia, a leader in patient intake, outreach and activation, has been named to the 2025 Capterra Shortlist in the Patient Engagement and Medical Scheduling categories. The Capterra Shortlist is an independent assessment that evaluates user reviews and online search activity to identify a list of market leaders that offer the top products in various software categories. "Being named to two of the 2025 Capterra Shortlists is an honor that reflects the positive reviews and feedback we receive from our healthcare provider clients," said Phreesia CEO Chaim Indig. "Our digital solutions help engage and empower patients to take a more active role their care, and this award is a welcome recogni
Phreesia, Inc. (NYSE:PHR) ("Phreesia") today announced that it will release its fiscal second quarter 2026 financial results after the close of market trading on Thursday, Sept. 4, 2025. Phreesia will issue a press release announcing its quarterly results and the company's quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal second quarter results starting at 5PM Eastern Time on the same day. To participate in the company's live conference call and webcast, please dial (800) 715-9871, or (646) 307-1963 for international participants, using conference code number 7404611, or vi
Patients with chronic obstructive pulmonary disease (COPD) face significant challenges, but conversations with healthcare providers can play a critical role in helping patients understand their condition, set realistic goals, ease symptom burden and improve their quality of life, according to new research from the COPD Foundation and Phreesia. COPD is a chronic and progressive lung disease that affects more than 16 million people in the United States and is the sixth leading cause of death. The study, published in Chronic Obstructive Pulmonary Diseases: The Journal of the COPD Foundation, with funding support from Verona Pharma, was based on voluntary surveys from 1,615 COPD patients in
Phreesia, a leader in patient intake, outreach and activation, has been named to Black Book Research's 2025 list of Top-Rated Vendors for Patient Access and Front-End Management Solutions in Revenue Cycle Management (RCM). The awards program is based on survey responses collected from 11,500+ healthcare finance professionals, administrators and RCM specialists. Phreesia was selected as the 2025 Top-Rated Vendor for Patient Registration and Intake Solutions for Ambulatory and Physician Practices. "It's an honor to be named a top-rated vendor by Black Book Research," said Phreesia CEO Chaim Indig. "Our solutions help healthcare organizations overcome RCM challenges while also driving strong
Phreesia, a leader in patient intake, outreach and activation, is proud to announce that Kristin Roberts, Vice President of Product Management, has been named in Becker's Hospital Review's 2025 list of the 100 Women in Health IT to Know. "Women are leading the charge in transforming the future of healthcare through innovation in health IT," Becker's said in its announcement of the list. "These trailblazing leaders are streamlining administrative processes, eliminating inefficiencies, standardizing workflows and driving meaningful change across the industry." In her role, Kristin drives Phreesia's product vision and roadmap to meet the evolving needs of healthcare organizations, improve
Phreesia, Inc. (NYSE:PHR) ("Phreesia" or the "Company") announced financial results today for the fiscal first quarter ended April 30, 2025. "Our fiscal year 2026 is off to a strong start. I am grateful to our team for their continued commitment to our mission, vision and values. I believe our performance is a reflection of our team truly living our values," said CEO and Co-Founder Chaim Indig. Please visit the Phreesia investor relations website at ir.phreesia.com to view the Company's Q1 Fiscal 2026 Stakeholder Letter. Fiscal First Quarter Ended April 30, 2025 Highlights Total revenue was $115.9 million in the quarter, up 15% year-over-year. Average number of healthcare servi
Phreesia, Inc. (NYSE:PHR) ("Phreesia") today announced that it will now release its fiscal first quarter 2026 financial results prior to the open of market trading on Wednesday, May 28, 2025. Phreesia previously announced that it would release the results after the close of market trading on the same day. Phreesia will issue a press release announcing its quarterly results and the company's quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal first quarter results starting at 8:30AM Eastern Time on the same day. To participate in the company's live conference call and webcast,
Phreesia, Inc. (NYSE:PHR) ("Phreesia") today announced that it will release its fiscal first quarter 2026 financial results after the close of market trading on Wednesday, May 28, 2025. Phreesia will issue a press release announcing its quarterly results and the company's quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal first quarter results starting at 5PM Eastern Time on the same day. To participate in the company's live conference call and webcast, please dial (800) 715-9871, or (646) 307-1963 for international participants, using conference code number 7404611, or visit
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
Mizuho initiated coverage of Phreesia with a rating of Outperform and set a new price target of $36.00
RBC Capital Mkts upgraded Phreesia from Sector Perform to Outperform and set a new price target of $32.00 from $24.00 previously
Truist initiated coverage of Phreesia with a rating of Buy and set a new price target of $35.00
DA Davidson upgraded Phreesia from Neutral to Buy and set a new price target of $32.00 from $30.00 previously
Barclays initiated coverage of Phreesia with a rating of Overweight and set a new price target of $29.00
Stephens initiated coverage of Phreesia with a rating of Overweight and set a new price target of $37.00
Needham reiterated coverage of Phreesia with a rating of Buy and set a new price target of $40.00 from $35.00 previously
Citigroup upgraded Phreesia from Neutral to Buy and set a new price target of $40.00
SVB Leerink upgraded Phreesia from Mkt Perform to Outperform and set a new price target of $34.00 from $31.00 previously
DA Davidson initiated coverage of Phreesia with a rating of Neutral and set a new price target of $25.00
SCHEDULE 13G - Phreesia, Inc. (0001412408) (Subject)
SCHEDULE 13G/A - Phreesia, Inc. (0001412408) (Subject)
SCHEDULE 13G/A - Phreesia, Inc. (0001412408) (Subject)
8-K - Phreesia, Inc. (0001412408) (Filer)
8-K - Phreesia, Inc. (0001412408) (Filer)
Live Leadership Updates
Phreesia will work with the NAI to shape the national conversation around data privacy and promote consumer choice and transparency As part of the company's ongoing commitment to consumer data privacy, Phreesia is pleased to announce it has joined the Network Advertising Initiative (NAI), a non–profit organization and the leading self-regulatory association dedicated to responsible data collection and use for digital advertising. As a member, Phreesia will work with the NAI to promote consumer-centric privacy practices in healthcare and take a leadership role in shaping the national conversation around data privacy. "We are excited to join the NAI, an organization that shares our dedicati
Phreesia, a leader in patient intake, outreach and activation, is proud to announce that Audrey Gato, Vice President of Client Solutions, has been named to The Software Report's list of the Top 50 Women Leaders in SaaS of 2023. Honorees were chosen based on their leadership and contributions to the Software-as-a-Service industry. This is the sixth consecutive year a female leader from Phreesia has been named to the list. Previous Phreesia awardees include Allison Hoffman, General Counsel; Kristin Roberts, Vice President of Product Management; Kharen Hauck, Vice President of Marketing; Amy VanDuyn, Senior Vice President of Human Resources; and Sara DiNardo, Vice President of Client Solutio
This live feed shows all institutional transactions in real time.
SC 13G/A - Phreesia, Inc. (0001412408) (Subject)
SC 13G/A - Phreesia, Inc. (0001412408) (Subject)
SC 13G/A - Phreesia, Inc. (0001412408) (Subject)
SC 13G/A - Phreesia, Inc. (0001412408) (Subject)
SC 13G/A - Phreesia, Inc. (0001412408) (Subject)
SC 13G/A - Phreesia, Inc. (0001412408) (Subject)
SC 13G/A - Phreesia, Inc. (0001412408) (Subject)
SC 13G/A - Phreesia, Inc. (0001412408) (Subject)
Live finance-specific insights
Phreesia, Inc. (NYSE:PHR) ("Phreesia") today announced that it will release its fiscal second quarter 2026 financial results after the close of market trading on Thursday, Sept. 4, 2025. Phreesia will issue a press release announcing its quarterly results and the company's quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal second quarter results starting at 5PM Eastern Time on the same day. To participate in the company's live conference call and webcast, please dial (800) 715-9871, or (646) 307-1963 for international participants, using conference code number 7404611, or vi
Phreesia, Inc. (NYSE:PHR) ("Phreesia" or the "Company") announced financial results today for the fiscal first quarter ended April 30, 2025. "Our fiscal year 2026 is off to a strong start. I am grateful to our team for their continued commitment to our mission, vision and values. I believe our performance is a reflection of our team truly living our values," said CEO and Co-Founder Chaim Indig. Please visit the Phreesia investor relations website at ir.phreesia.com to view the Company's Q1 Fiscal 2026 Stakeholder Letter. Fiscal First Quarter Ended April 30, 2025 Highlights Total revenue was $115.9 million in the quarter, up 15% year-over-year. Average number of healthcare servi
Phreesia, Inc. (NYSE:PHR) ("Phreesia") today announced that it will now release its fiscal first quarter 2026 financial results prior to the open of market trading on Wednesday, May 28, 2025. Phreesia previously announced that it would release the results after the close of market trading on the same day. Phreesia will issue a press release announcing its quarterly results and the company's quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal first quarter results starting at 8:30AM Eastern Time on the same day. To participate in the company's live conference call and webcast,
Phreesia, Inc. (NYSE:PHR) ("Phreesia") today announced that it will release its fiscal first quarter 2026 financial results after the close of market trading on Wednesday, May 28, 2025. Phreesia will issue a press release announcing its quarterly results and the company's quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal first quarter results starting at 5PM Eastern Time on the same day. To participate in the company's live conference call and webcast, please dial (800) 715-9871, or (646) 307-1963 for international participants, using conference code number 7404611, or visit
Phreesia, Inc. (NYSE:PHR) ("Phreesia" or the "Company") announced financial results today for the fiscal fourth quarter and fiscal year ended January 31, 2025. "We are pleased with our solid finish to fiscal 2025 and I am excited about the new products we have introduced over the past several quarters that improve medication adherence and the overall patient and provider experience," said CEO and Co-Founder Chaim Indig. Please visit the Phreesia investor relations website at ir.phreesia.com to view the Company's Q4 Fiscal 2025 Stakeholder Letter. Fiscal Fourth Quarter Ended January 31, 2025 Highlights Total revenue was $109.7 million in the quarter, up 15% year-over-year. Average num
Phreesia, Inc. (NYSE:PHR) ("Phreesia") today announced that it will release its fiscal fourth quarter and fiscal year 2025 financial results after the close of market trading on Wednesday, March 12, 2025. Phreesia will issue a press release announcing its quarterly and full year results and the company's quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal fourth quarter and fiscal year 2025 results starting at 5PM Eastern Time on the same day. To participate in the company's live conference call and webcast, please dial (800) 715-9871, or (646) 307-1963 for international part
Phreesia, Inc. (NYSE:PHR) ("Phreesia" or the "Company") announced financial results today for the fiscal third quarter ended October 31, 2024. "We are excited about the future here at Phreesia," said CEO and Co-Founder Chaim Indig. "Our network continues to grow, adoption of our current offerings is increasing, and we are beginning to see the promise of new solutions we are investing in." Please visit the Phreesia investor relations website at ir.phreesia.com to view the Company's Q3 Fiscal Year 2025 Stakeholder Letter. Fiscal Third Quarter Ended October 31, 2024 Highlights Total revenue was $106.8 million in the quarter, up 17% year-over-year. Average number of healthcare servi
Phreesia, Inc. (NYSE:PHR) ("Phreesia") today announced that it will release its fiscal third quarter 2025 financial results after the close of market trading on Monday, Dec. 9, 2024. Phreesia will issue a press release announcing its quarterly results and the company's quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal third quarter results starting at 5PM Eastern Time on the same day. To participate in the company's live conference call and webcast, please dial (800) 715-9871, or (646) 307-1963 for international participants, using conference code number 7404611, or visit th
Phreesia, Inc. (NYSE:PHR) ("Phreesia" or the "Company") announced financial results today for the fiscal second quarter ended July 31, 2024. "We reached another very important milestone in Phreesia's evolution by crossing over to positive Free cash flow1 in the fiscal second quarter of 2025," said CEO and Co-Founder Chaim Indig. "We believe this milestone marks the start of a new era for Phreesia in which we are able to deploy internally generated cash to drive stakeholder value." Please visit the Phreesia investor relations website at ir.phreesia.com to view the Company's Q2 Fiscal Year 2025 Stakeholder Letter. Fiscal Second Quarter Ended July 31, 2024 Highlights Total revenue was
Phreesia, Inc. (NYSE:PHR) ("Phreesia") today announced that it will release its fiscal second quarter 2025 financial results after the close of market trading on Wednesday, Sept. 4, 2024. Phreesia will issue a press release announcing its quarterly results and the company's quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal second quarter results starting at 5PM Eastern Time on the same day. To participate in the company's live conference call and webcast, please dial (800) 715-9871, or (646) 307-1963 for international participants, using conference code number 7404611, or v